Seehra Jasbir bought KROS
February 24, 2026 · Form 4 insider transaction
Seehra Jasbir bought 100,000 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderSeehra Jasbir
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest in one-fourth (1/4th) increments upon the closing price of the Issuer's common stock equaling or exceeding 125%, 150%, 175% and 200%, respectively, of the exercise price for 30 calendar days between February 24, 2026 and February 24, 2031, subject to the Reporting Person's continuous service through each vesting date.